Abstract
Background Economic burden and cost-related evidence from primary data of road traffic crashes (RTCs) in Nepal are limited.
Aim This study assessed the disability-adjusted life years (DALYs) and the cost associated with RTCs.
Methods We carried out a retrospective cross-sectional institution-based survey of the victims of road traffic crashes (RTCs) in the last one year to 45 days prior in Kaski, a mid-hilly district of Nepal. A total of 107 RTC victims, registered in different hospitals, the Police Offices and health insurance offices, were approached. A semi-structured interview schedule was used to collect information. Data were entered in EpiData and then imported to the Statistical Package for Social Sciences (SPSS) for further analysis. Descriptive statistics were obtained by calculating the costs and DALYs, and inferential analysis was carried to explore the relationship of DALYs with independent variables.
Results Of 107 victims, more than one-third (37.4%) were 25-44 year-age group; more than half (60.7%) were male. Cost per million person-years of RTC was around US $ 82800. Similarly, around 1018 DALYs per million person-years are attributed to RTC, and more than 99% of it was shared from YLL. We observed statistical significance (p<0.05) in the level of education, indirect cost and total cost with DALYs. Breadwinner males and motor-cyclists were the most frequent victims of RTC for which negligence, overtaking and high speed of the vehicle were the most frequent reasons for the injuries.
Conclusion Cost and DALYs associated to RTC of Kaski district were around US$ 82800 and 1018 per million person-years in 2017, respectively. Male motorcyclists of productive age-group were the most frequent victims.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted from Institutional Review Committee (IRC) of Pokhara University Research Center (PURC), Kaski, Nepal.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.